Sartorius Aktiengesellschaft (FRA:SRT4)

Germany flag Germany · Delayed Price · Currency is EUR
37.60
+0.80 (2.17%)
At close: Feb 20, 2026
Market Cap15.07B -3.0%
Revenue (ttm)3.54B +4.7%
Net Income154.90M +84.4%
EPS2.24 +84.2%
Shares Outn/a
PE Ratio97.28
Forward PE39.08
Dividend0.09 (0.26%)
Ex-Dividend DateMar 30, 2026
Volumen/a
Average Volume8
Open37.60
Previous Close36.80
Day's Range37.60 - 37.60
52-Week Range29.00 - 40.20
Betan/a
RSI53.46
Earnings DateFeb 3, 2026

About FRA:SRT4

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture... [Read more]

Industry Laboratory Analytical Instruments
Founded 1870
Employees 13,671
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol SRT4
Full Company Profile

Financial Performance

In 2025, FRA:SRT4's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.

Financial Statements